M&A Deal Summary |
|
|---|---|
| Date | 2024-12-25 |
| Target | WuXi AppTec - Advanced Therapies |
| Sector | Life Science |
| Buyer(s) | Altaris |
| Sellers(s) | WuXi AppTec |
| Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 2003 |
| PE ASSETS | 10.0B USD |
| Size | Mega |
| Type | Sector Focused |
Altaris is a specialist private equity firm that targets investments in the healthcare industry. Altaris focuses its investment activity across the healthcare sector, including pharmaceuticals, medical devices, healthcare services and healthcare IT. Altaris will consider both control and non-control investment situations requiring $15 to $50 million of equity capital. Prospective investment situations include corporate carve-outs, leveraged buyouts, and growth equity/recapitalization investments. Altaris was formed in 2004 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 37 of 37 |
| Sector (Life Science) | 9 of 9 |
| Type (Divestiture) | 7 of 7 |
| Country (China) | 1 of 1 |
| Year (2024) | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-09-24 |
Minaris
Allendale, New Jersey, United States Minaris is a cell therapy contract development and manufacturing organization (“CDMO”) that provides autologous and allogeneic manufacturing services for pharmaceutical and biotech customers globally. Minaris was founded in 1999 and is based in Allendale, New Jersey. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 2000 |
| Sector | Life Science |
| Employees | 38,134 |
| Revenue | 40.3B CNY (2023) |
WuXi AppTec is a provider of pharmaceutical, biotechnology, and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi AppTec was founded in 2000 and is based in Shanghai, China.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 4 |
| Sector (Life Science) | 3 of 4 |
| Type (Divestiture) | 1 of 2 |
| Country (China) | 2 of 2 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-12-10 |
CANbridge
Suzhou, China CANbridge is a biotechnology company focused on developing and commercializing rare disease therapeutics in China. CANbridge was founded in 2012 and is based in Suzhou, China. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-01-17 |
WuXi AppTec - Medical Device Testing Operations
Minnesota, United States WuXi AppTec's Medical Device Testing Operations provides clinical research and testing solutions. |
Sell | - |
